Samsara BioCapital »

Rani Therapeutics Hldgs shares owned by Samsara BioCapital

Quarter-by-quarter ownership of Rani Therapeutics Hldgs (RANI) shares owned by Samsara BioCapital from 13F filings

Historical chart of Samsara BioCapital investment in Rani Therapeutics Hldgs

Tip: Access up to 7 years of quarterly data

All positions including Rani Therapeutics Hldgs held by Samsara BioCapital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rani Therapeutics Hldgs by Samsara BioCapital

Quarter filed Position value Share count Share price at filing
2025-12-31 $12M 8.5M 1.35

More positions owned by Samsara BioCapital

Scholar Rock Hldg Corp (SRRK)
Mineralys Therapeutics (MLYS)
Kalaris Therapeutics (KLRS)
Septerna (SEPN)
Alumis (ALMS)
Neurogene (NGNE)
Inventiva Sa Ads (IVA)
Gossamer Bio (GOSS)
Upstream Bio (UPB)
Aquestive Therapeutics (AQST)
Jade Biosciences Com New (JBIO)
Vtv Therapeutics Cl A New (VTVT)
Rani Therapeutics Hldgs Com Cl A (RANI)
Palvella Therapeutics Inc Ne (PVLA)
Abivax Sa Sponsored Ads (ABVX)

View all positions for Samsara BioCapital

Top funds holding Rani Therapeutics Hldgs

Samsara BioCapital
AWM Investment Company
Vanguard Group
Susquehanna International
Jane Street
Geode Capital Management
Nan Fung Group Holdings
683 Capital Management
Citadel Advisors
State Street Corporation
Squarepoint Ops
United Services Automobile Association
Goldman Sachs Group
Kestra Private Wealth Services
Takeda Pharmaceutical

View all funds holding Rani Therapeutics Hldgs